BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11234301)

  • 41. [Primary gastric lymphoma].
    Barreda B F; Gómez P R; Quispe L D; Sánchez L J; Combe G J; Casanova M L; Celis Z J
    Rev Gastroenterol Peru; 2004; 24(3):238-62. PubMed ID: 15483686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
    Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
    Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [MALT-lymphoma--conservative therapy].
    Fischbach W
    Praxis (Bern 1994); 1996 Nov; 85(45):1455-8. PubMed ID: 8975357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superficial spreading type of early gastric lymphomas.
    Kitamura K; Yamaguchi T; Okamoto K; Takahashi T; Sugihara H
    Anticancer Res; 1995; 15(6B):2829-33. PubMed ID: 8669873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma.
    Ohashi S; Segawa K; Okamura S; Urano H; Kanamori S; Ishikawa H; Hara K; Hukutomi A; Shirai K; Maeda M
    Cancer; 2000 May; 88(10):2210-9. PubMed ID: 10820341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas.
    Hagel C; Krog B; Laas R; Stavrou DK
    J Exp Clin Cancer Res; 1999 Sep; 18(3):305-9. PubMed ID: 10606174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas.
    Chang CC; Liu YC; Cleveland RP; Perkins SL
    Am J Clin Pathol; 2000 Apr; 113(4):512-8. PubMed ID: 10761452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary MALT lymphomas of the stomach: a pathological study of 18 cases.
    Venizelos I; Tamiolakis D; Bolioti S; Nikolaidou S
    Rev Esp Enferm Dig; 2007 May; 99(5):270-4. PubMed ID: 17650936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful.
    Martin-Arruti M; Vaquero M; Díaz de Otazu R; Zabalza I; Ballesteros J; Roncador G; García-Orad A
    Histopathology; 2012 Apr; 60(5):785-92. PubMed ID: 22321048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of MIB-1/KI-67 and bcl-2 in gastric carcinoma. Relationship with clinico-pathological factors].
    Sundblad AS; Tamayo R
    Acta Gastroenterol Latinoam; 1995; 25(2):67-72. PubMed ID: 8525762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.
    He M; Gao L; Zhang S; Tao L; Wang J; Yang J; Zhu M
    Gastric Cancer; 2014; 17(3):431-41. PubMed ID: 24232982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases.
    Wang YG; Zhao LY; Liu CQ; Pan SC; Chen XL; Liu K; Zhang WH; Yang K; Chen XZ; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Medicine (Baltimore); 2016 Aug; 95(31):e4250. PubMed ID: 27495029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depth of infiltration of primary gastric B-cell lymphomas--correlations with proliferation, apoptosis and expression of p53 and bcl-2.
    Eidt S; Lorenzen J; Ortmann M
    Pathol Res Pract; 1996 Sep; 192(9):925-30. PubMed ID: 8950759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [MALT stomach lymphoma: is there a standardized therapy?].
    Fischbach W
    Z Gastroenterol; 1998 Dec; 36(12):1099-102. PubMed ID: 10025061
    [No Abstract]   [Full Text] [Related]  

  • 56. Management of primary gastric lymphomas from a surgeon's viewpoint.
    Ishizuka H; Kubota T; Hayashi N; Otani Y; Kumai K; Kitajima M
    Oncol Rep; 1999; 6(1):103-6. PubMed ID: 9864410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Gastric malignant lymphoma].
    Yoshita H; Sugiyama T
    Nihon Rinsho; 2012 Jul; 70(7):1253-62. PubMed ID: 22844813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
    Skacel M; Ross CW; Hsi ED
    Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathologic study of primary gastric lymphoma of B cell phenotype with special reference to low-grade B cell lymphoma of mucosa-associated lymphoid tissue among the Japanese.
    Akaza K; Motoori T; Nakamura S; Koshikawa T; Kitoh K; Futamura N; Nakamura T; Kojima M; Kuroda M; Kasahara M
    Pathol Int; 1995 Nov; 45(11):832-45. PubMed ID: 8581146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index.
    Nakamura S; Akazawa K; Yao T; Tsuneyoshi M
    Cancer; 1995 Oct; 76(8):1313-24. PubMed ID: 8620403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.